SEC Form 3 · accession 0001104659-16-143486
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seth H. Z. Fischer
Director
Period of report
Sep 6, 2016
Accepted (ET)
Sep 7, 2016 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted stockF1 | holding | — | — | — | 6,600 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options (right to buy)F2 | $1.73 | holding | — | — | — | — | Sep 6, 2026 | Common Stock | 15,400 | — | D |
Explanation of responses
- F1Each share of restricted stock represents the right to receive, at settlement, one share of common stock. All shares of restricted stock vest on September 6, 2017.
- F2Options to purchase shares of common stock vest monthly over 24 months beginning on September 6, 2017.